Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding XBI?
Track your performance easily
XBI Price & Analysis
XBI ETF Chart & Stats
Day’s Range― - ―
52-Week Range$71.99 - $105.47
Previous Close$94.01
VolumeN/A
Average Volume (3M)7.96M
AUM6.73B
NAV93.18
Expense Ratio0.35%
Holdings Count144
Beta1.35
Inception DateJan 31, 2006
Last Dividend Ex-Date
Sep 23, 2024Dividend Yield
0.14 (0.15%)Shares Outstanding76,800,000
Standard Deviation0.08
10 Day Avg. Volume12,666,863
30 Day Avg. Volume7,960,688
Alpha-0.00490
SPDR S&P BIOTECH ETF (XBI) Fund Flow Chart
SPDR S&P BIOTECH ETF (XBI) 1 year Net Flows: -$644M
XBI ETF News
XBI ETF FAQ
What was XBI’s price range in the past 12 months?
XBI lowest ETF price was $71.99 and its highest was $105.47 in the past 12 months.
What is the AUM of XBI?
As of Nov 19, 2024 The AUM of XBI is 6.73B.
Is XBI overvalued?
According to Wall Street analysts XBI’s price is currently Undervalued.
Does XBI pay dividends?
XBI pays a Semiannually dividend of $0.01 which represents an annual dividend yield of 0.15%. See more information on XBI dividends here
How many shares outstanding does XBI have?
XBI has 76,800,000 shares outstanding.
Which hedge fund is a major shareholder of XBI?
Among the largest hedge funds holding XBI’s share is Sivik Global Healthcare LLC. It holds XBI’s shares valued at 30M.
XBI ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Natera Inc.
3.44%
Incyte
2.98%
United Therapeutics Corp.
2.85%
Gilead Sciences
2.84%
Insmed
2.65%
Neurocrine Biosciences
2.62%
Vertex Pharmaceuticals Inc.
2.48%
Alnylam Pharmaceuticals
2.37%
Abbvie
2.30%
Sarepta Therapeutics Inc.
2.30%
Total26.83%
ETF Description
SPDR S&P BIOTECH ETF
XBI tracks an equal-weighted index of US biotechnology stocks.